Review of Cerliponase Alfa: Recombinant Human Enzyme Replacement Therapy for Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2.

Saved in:
Bibliographic Details
Title: Review of Cerliponase Alfa: Recombinant Human Enzyme Replacement Therapy for Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2.
Authors: Lewis G; Department Pharmacy Practice, MCPHS University School of Pharmacy-Worcester/Manchester, Worcester, MA, USA.; Sanofi Genzyme, Cambridge, MA, USA., Morrill AM; Department Pharmacy Practice, MCPHS University School of Pharmacy-Worcester/Manchester, Worcester, MA, USA., Conway-Allen SL; Department Pharmacy Practice, MCPHS University School of Pharmacy-Worcester/Manchester, Worcester, MA, USA., Kim B; Department Pharmacy Practice, MCPHS University School of Pharmacy-Worcester/Manchester, Worcester, MA, USA.; Sanofi Genzyme, Cambridge, MA, USA.
Source: Journal of child neurology [J Child Neurol] 2020 Apr; Vol. 35 (5), pp. 348-353. Date of Electronic Publication: 2019 Dec 29.
Publication Type: Journal Article; Review
Journal Info: Publisher: Sage Country of Publication: United States NLM ID: 8606714 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1708-8283 (Electronic) Linking ISSN: 08830738 NLM ISO Abbreviation: J Child Neurol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1708-8283
DOI:10.1177/0883073819895694